Release Date: 19/02/15 11:43 Summary: Half Yearly Report and Accounts Price Sensitive: Yes Download Document 1.28MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%